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Background: The clinical course of patients with acute ischemic stroke tends to be unstable. Understanding
the factors contributing to the progression of stroke is important for the appropriate management of patients.
This study investigated the factors related to 3-month mortality at admission in patients with first-ever acute
ischemic stroke.
Methods: Patients with first-ever acute ischemic stroke consecutively admitted to a medical center in Taiwan
within 48 hours after stroke onset were prospectively followed-up for 3 months. All deaths during this 3-
month post-stroke period were analyzed. We evaluated only those characteristics that could be assessed at
admission. Multivariate logistic regression analysis was used to identify the main predictors of 3-month stroke-
related mortality.
Results: In the 360 enrolled patients, the inhospital mortality rate was 7.8% (28 deaths), and the 3-month
mortality rate was 9.7% (35 deaths). Twenty-seven deaths (77%) were stroke-related. Risk factors for mortality
at 3 months included sex (odds ratio [OR], 3.18; 95% confidence interval [CI], 1.08–9.41; p = 0.036), National
Institutes of Health Stroke Scale (NIHSS) at admission (per unit increase: OR, 1.17; 95% CI, 1.12–1.22; p <
0.001), history of cardiac disease (OR, 2.73; 95% CI, 1.04–7.16; p = 0.042), and posterior circulation stroke
(OR, 5.25; 95% CI, 1.92–14.36; p = 0.001).
Conclusion: This study of hospital-based data on patients with first-ever acute ischemic stroke in Taiwan
found that initial NIHSS, posterior circulation stroke and history of cardiac disease were risk factors for 3-
month mortality. [J Formos Med Assoc 2006;105(4):310–317]
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Stroke is the second most common cause of mor-
tality in Taiwan, and a major global health care
problem. In 2003, there were about 12,400 deaths
due to cerebrovascular disease in Taiwan,1 which
is equivalent to one resident dying of stroke ap-
proximately every 43 minutes. The incidence of
first-ever stroke in people aged * 36 years in
Taiwan has been reported to be 330 per 100,000,
and 71% of cases were ischemic stroke.2 Early
risk stratification of ischemic stroke victims, using
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reliable and simple prognostic models, has yield-
ed important clinical estimates of mortality risk,
provided guidance for decision-making in stroke
care, and has been useful in the economic eval-
uation of various health care services. However,
data on mortality (short-term or long-term) in
patients with ischemic stroke are limited in
Taiwan,2–6 even though mortality data on stroke
of all types are available.2–5,7–9
Many studies have suggested numerous prog-
ORIGINAL ARTICLE
Predicting 3-month Mortality Among
Patients Hospitalized for First-ever Acute
Ischemic Stroke
Ku-Chou Chang, Mei-Chiun Tseng,1* Teng-Yeow Tan, Chia-Wei Liou
©2006 Elsevier & Formosan Medical Association
311J Formos Med Assoc | 2006 • Vol 105 • No 4
Predicting 3-month mortality after ischemic stroke
set. Although thrombolytic therapy was used in
only a limited number of cases in Taiwan during
the study period, and it has not been demonstrat-
ed to be able to decrease mortality,19 we chose to
exclude from the analysis patients who received
either intravenous or intra-arterial thrombolysis
to avoid potential confounding. The remaining
360 patients formed the cohort of this study.
Deaths occurring up to 3 months after hospital
admission were identified by linkages with the
national Death Registry files of the Department of
Health (DOH).
Predictor variables were selected for prospec-
tive evaluation on the basis of evidence in the lit-
erature and clinical judgment. To develop a model
for early prediction, we evaluated only those
factors that could be assessed at the time of ad-
mission. These included the demographic factors
of age, sex, comorbidity (presence or absence of
history of hypertension, diabetes mellitus or hy-
percholesterolemia), smoking, congestive heart
failure, valvular heart disease, atrial fibrillation,
and history of cardiac disease (history of arrhyth-
mia, angina pectoris, ischemic heart disease, and/
or abnormalities identified from the initial elec-
trocardiogram). The clinical factors assessed were
stroke severity as measured by the National In-
stitutes of Health Stroke Scale (NIHSS), stroke
subtype, body temperature (recorded by the tym-
panic thermometer at hospital presentation), sys-
tolic blood pressure, serum total cholesterol and
triglyceride levels at admission.
The ischemic stroke subtype was determined
based on criteria modified from the Trial of
ORG10172 in Acute Stroke Treatment (TOAST).20
For the purposes of this study, stroke subtype was
dichotomized as small-vessel occlusion or not.
Stroke subtype was categorized into anterior cir-
culation and posterior circulation to investigate
the potential association of posterior circulation
ischemic stroke with high mortality.21,22
All but three patients in this study had brain
computed tomography (CT) exams. Magnetic re-
sonance imaging (MRI) was performed in 73 pa-
tients (20.3%), inclusive of the three patients who
did not have CT exams. We did not include any
nostic factors of acute stroke.10 However, data from
participants in clinical trials may be subject to var-
ious inclusion criteria that might not be
reflected in practice.11–14 Little is known about the
prognostic value of reported factors in daily clin-
ical practice for first-ever acute ischemic stroke. Ex-
amination of the factors contributing to stroke
mortality may have important impact on future
stroke trials and stroke management. It has also
been established that externally or internally vali-
dated prognostic models can provide more ac-
curate prediction of outcome after stroke.13–17
The purpose of this hospital-based study
was to identify risk factors for 3-month mortality
in patients with first-ever acute ischemic stroke.
We focused on patient characteristics that were
available at the time of admission. This study also
investigated the 3-month mortality in these pa-
tients to serve as a basis for hypothesis generation
for future large prospective studies in Taiwan.
Methods
A series of 368 patients with first-ever ischemic
stroke consecutively admitted to the Department
of Neurology, Chang Gung Memorial Hospital,
Kaohsiung, Taiwan, between September 1998
and October 1999 within 48 hours after stroke
onset were followed-up for 3 months. Patients eli-
gible for this prospective follow-up study were en-
rolled if they met the following criteria: (1) diag-
nosis of first-ever ischemic stroke with no history
of stroke or transient ischemic attack; (2) acute
stroke, defined as meeting the criteria for ischemic
stroke-onset within 48 hours before admission.
The methods of this hospital-based study have
been reported previously.18 Overall, during the
study period, about 1500 patients admitted due
to ischemic stroke were screened for possible en-
rollment.
In the study cohort, two patients received in-
travenous thrombolysis with recombinant tissue
plasminogen activator within 3 hours after on-
set, and six patients received intra-arterial throm-
bolysis with urokinase within 6 hours after on-
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imaging variables in the model, but did use im-
aging information to clarify posterior circulation
subtype.
All potential predictor variables were first
examined by univariate analysis, with and with-
out adjustment for stroke severity. Age, initial
NIHSS score, body temperature, systolic blood
pressure, serum total cholesterol level, and serum
triglyceride level were considered as continuous
variables. Because of concern about the number
of events per variable considered in the model,15
certain data reduction or variable selection tech-
niques were implemented in the multivariate re-
gression analysis.
Candidate variables that were associated with
3-month mortality on univariate analysis (p )
0.20) after adjustment for NIHSS score at admis-
sion were included as potential covariates in a
multiple logistic regression model. All of these
potential covariates were entered simultane-
ously to avoid overfitting the data to the model.15
The level of significance for p values in the final
multivariate model was set at 0.05. We assessed
the model’s goodness-of-fit using the Hosmer-
Lemeshow goodness-of-fit statistic, and the mod-
el’s discrimination by calculating the area under
the receiver operating characteristic (ROC) curve.
The final model was internally validated using
the nonparametric bootstrap method with 1000
replications. Stata version 7.0 (Stata Corp, College
Park, TX, USA) was used for all analyses.
Results
The mean age of the 360 patients was 64.9 ±
12.7 years (range, 18–93 years); 207 patients
(58%) were male. Table 1 shows the patients’ dem-
ographic and clinical features. The mortality
rates for the study cohort were 7.8% (28 deaths)
Table 1. Demographic and clinical characteristics of the study patients
Male (n = 207) Female (n = 153) Total (n = 360)
Demographic characteristics
Age*, yr 00065 (57–73) 00069 (57–75) 00067 (57–74)
Any comorbidity†, n (%) 132 (64)0 111 (73)0 243 (68)0
Hypertension† 112 (54)0 93 (61) 205 (57)0
Diabetes mellitus† 46 (22) 52 (34) 98 (27)
Hypercholesterolemia† 10 (5)0 4 (3) 14 (4)0
Smoking, n (%) 72 (35) 4 (3) 76 (21)
Congestive heart failure, n (%) 5 (2) 11 (7)0 16 (4)0
Valvular heart disease, n (%) 3 (1) 3 (2) 6 (2)
Atrial fibrillation, n (%) 14 (7)0 16 (10) 30 (8)0
History of cardiac disease, n (%) 89 (43) 60 (39) 149 (41)0
Clinical characteristics
NIHSS score at admission* 0005 (2–11) 0006 (3–16) 0006 (3–12)
Small-vessel occlusion, n (%) 126 (61)0 87 (57) 213 (59)0
Posterior circulation, n (%) 43 (21) 17 (11) 60 (17)
Body temperature*, °C (2.8‡) 0000.36.4 (36.1–36.8) 0000.36.7 (36.3–37.1) 0000.36.5 (36.2–37.0)
Blood pressure*, mmHg
Systolic (3.1‡) 0000163 (145–183) 0000169 (145–191) 0000165 (145–187)
Diastolic (3.6‡) 000090 (78–100) 00087 (78–99) 000088 (78–100)
Total cholesterol*, mg/dL (7.8‡) 0000178 (155–206) 0000195 (167–219) 0000188 (158–211)
Triglyceride*, mg/dL (8.3‡) 000112 (80–173) 000127 (90–191) 000120 (84–180)
*Expressed as median (25th – 75th percentile); †information that was unavailable was assumed to represent absence of the symptom;
‡percentage of patients with missing data. NIHSS = National Institutes of Health Stroke Scale.
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inhospital and 9.7% (35 deaths) at 3 months. Of
the 35 deaths, 27 (77%) were stroke-related;
other causes of death were diabetes mellitus (n =
3), heart disease (n = 3), cancer (n = 1), and other
disease (n = 1).
Results of the univariate analysis for all the
potential predictor variables considered are shown
in Table 2. The univariate analysis revealed that
p values of the following variables were less
than the pre-selected value (0.20) after adjustment
for NIHSS score at admission: sex (p = 0.013),
history of cardiac disease (p = 0.109), small-vessel
occlusion (p = 0.044), and posterior circulation
(p = 0.001). Valvular heart disease, atrial fibril-
lation and body temperature at admission were
associated with 3-month mortality in the univari-
ate analysis (in terms of the desirable statistical p
value) before adjustment for stroke severity, but
were no longer significant after adjustment for
stroke severity. In contrast, sex was a significant
predictor of death after adjustment for initial
NIHSS score, but not before.
As it is clear that the two kinds of classification
of stroke subtype (small-vessel occlusion and
posterior circulation) should not be included to-
gether in the model, we considered two multi-
variate models, each of them including sex, ini-
tial NIHSS score, and history of cardiac disease,
together with one of the two stroke subtype clas-
sification variables (model 1 for posterior cir-
culation, model 2 for small-vessel occlusion). Re-
sults of multivariate logistic regression analysis
using the two models for 3-month mortality are
shown in Table 3. The goodness-of-fit statistic
test indicated that the model that contained sex,
initial NIHSS score, history of cardiac disease, and
posterior circulation as predictors fitted reasona-
bly well (p = 0.635; or 0.254 based on the percen-
tile-type of grouping). The area under the ROC
curve was 0.909. Notably, when posterior circu-
lation was replaced by small-vessel occlusion,
the model also fitted reasonably well (p = 0.774;
or 0.819 based on the percentile-type of grouping),
with the area under the ROC curve being 0.901.
However, neither small-vessel occlusion nor his-
tory of cardiac disease was significantly associ-
ated with 3-month mortality in this model.
The bootstrap-corrected (bias-corrected meth-
od) 95% confidence interval (CI) of the area
under the ROC curve was 0.825–0.956 for the
Table 2. Univariate analysis of predictors of 3-month mortality
Unadjusted Severity-adjusted
Variable
OR (95% CI) p OR (95% CI) p
Age, per 10 yr 1.42 (1.04–1.94) 0.029 1.11 (0.80–1.53) 0.525
Men 1.28 (0.62–2.63) 0.501 3.50 (1.30–9.42) 0.013
Any comorbidity 1.44 (0.65–3.18) 0.369 1.62 (0.63–4.19) 0.318
Smoking 0.60 (0.22–1.59) 0.302 1.57 (0.48–5.17) 0.458
Congestive heart failure 1.35 (0.29–6.18) 0.702 0.41 (0.70–2.41) 0.325
Valvular heart disease 10.06 (1.95–51.93) 0.006 3.34 (0.50–22.19) 0.211
Atrial fibrillation 4.08 (1.66–10.04) 0.002 1.15 (0.37–3.56) 0.814
History of cardiac disease 2.64 (1.12–1.21) 0.008 2.04 (0.85–4.88) 0.109
Initial NIHSS, per unit 1.16 (1.75–2.57) < 0.001 NA NA
Small-vessel occlusion 0.07 (0.02–0.21) < 0.001 0.29 (0.09–0.97) 0.044
Posterior circulation 7.13 (3.41–14.92) < 0.001 4.93 (1.90–12.80) 0.001
Body temperature, per 1°C 2.03 (1.23–3.36) 0.006 1.13 (0.62–2.09) 0.683
Systolic BP, mmHg (per 10-unit increase) 0.99 (0.89–1.10) 0.882 1.03 (0.92–1.17) 0.585
TC, mg/dL (per 10-unit increase) 0.99 (0.90–1.08) 0.770 0.96 (0.87–1.07) 0.480
TG, mg/dL (per 10-unit increase) 0.97 (0.92–1.02) 0.274 0.99 (0.93–1.05) 0.734
OR = odds ratio; CI = confidence interval; NIHSS = National Institutes of Health Stroke Scale; BP = blood pressure; TC = total cholesterol;
TG = triglyceride; NA = not applicable.
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model using posterior circulation as the stroke
subtype variable, and 0.829–0.945 for the model
using small-vessel occlusion.
Furthermore, we noted that the model using
NIHSS alone as an independent predictor of 3-
month mortality fitted quite well and had ex-
cellent discrimination: the p value of the Hosmer-
Lemeshow goodness-of-fit statistic was 0.705,
and the area under the ROC curve was 0.866
(bootstrap-corrected 95% CI, 0.778–0.932). The
corresponding odds ratio was 1.16 per unit increase
(Table 2).
Discussion
This prospective hospital-based study identified
stroke severity at admission as measured by NIHSS
score as the strongest predictor of 3-month
mortality, with odds ratio 1.16 per point (p <
0.001). Stroke severity at admission was found in
many previous studies to be highly predictive of
stroke outcome.11–14,17,18,23,24 Our results demon-
strate the strength and importance of the NIHSS
score in the early prediction of stroke mortality
and in stroke management. Based on our analy-
sis of data from daily practice, together with the
predictive ability of mortality and outcomes shown
in previous clinical trials, we may postulate that
the standard neurologic assessments of stroke pa-
tients should include the domain of evaluating
stroke severity.
Our data were obtained from an observational
hospital-based study, which is naturally subject
to certain selection bias.25 In contrast, previous
clinical trials generally focused on patients with
characteristics that were more amenable to follow-
up, and data collected from community settings
might be subject to lower standards of care that
could contaminate the survival evaluation.16 De-
spite its limitations, this study extends prior ob-
servations in Taiwan and refines the relation-
ship between initial stroke severity and 3-month
mortality.
A previous study identified gender as a pre-
dictor of functional independence but not mortal-
ity.17 In this study, both multivariate models sug-
gested that men had a greater risk of mortality
within 3 months post-stroke than women. How-
ever, caution is warranted on how this finding is
interpreted until further confirmation is obtained.
In particular, no significant difference in mean age
between men and women was found in this study
(64.2 years in men vs. 66.0 years in women; p =
0.181), and men had less severe neurologic im-
pairment at hospital presentation than women
(NIHSS score 8.3 vs. 10.9; p = 0.008).
This study did not find a significant associa-
tion between age and 3-month mortality. This may
be attributable to the limited clinical evaluation,
the good premorbid physical condition of this co-
hort, and possible effects of initial stroke severity.
The relatively low mean age of patients in this
study also could have influenced the observed
results and the prevalence of other risk factors.
Further exploration revealed that patients with
a history of cardiac disease were relatively older
(67.8 vs. 62.9 years; p < 0.001), but no difference
Table 3. Multivariate analysis of predictors of 3-month mortality
Model 1* Model 2*
Variable
OR (95% CI) p OR (95% CI) p
Sex, male 3.18 (1.08–9.41) 0.036 3.38 (1.25–9.14) 0.016
Initial NIHSS, per unit 1.17 (1.12–1.22) < 0.001 1.14 (1.09–1.19) < 0.001
History of cardiac disease 2.73 (1.04–7.16) 0.042 1.77 (0.71–4.41) 0.223
Posterior circulation 5.25 (1.92–14.36) 0.001 NA NA
Small-vessel occlusion NA NA 0.36 (0.10–1.26) 0.111
*Model 1 uses posterior circulation as the stroke subtype variable and Model 2 uses small-vessel occlusion. OR = odds ratio; CI =
confidence interval; NIHSS = National Institutes of Health Stroke Scale; NA = not applicable.
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in age was found among the subgroups of stroke
subtype (p > 0.05 for both classifications of stroke
subtype).
Prestroke functional independence has been
shown to be related to stroke prognosis in some
studies.16,26 However, in those studies, the effects
of stroke severity were not examined, possibly
due to data limitations. After adjusting for stroke
severity, many potential prognostic predictors
lost statistical significance. Similarly, even though
body temperature at admission was identified
as associated with stroke mortality,27 it was not
significantly associated with 3-month mortality
after adjustment for stroke severity. Hence, our
findings suggest that stroke severity may be es-
sential to early risk stratification and in predicting
responses to any intervention.
Patients with posterior circulation stroke had
a significantly higher risk of 3-month mortality af-
ter acute ischemic stroke. This observation supports
the recognized association of poor prognostic out-
come and posterior circulation stroke. Although
a previous study noted that vertebrobasilar oc-
clusive disease may have a good outcome,21 cau-
tion is warranted when using brain CT to identify
acute ischemic lesions in cases of posterior fossa
in an emergency setting. Additionally, subtype
classification, which is based solely on clinical
impressions, must be interpreted with extreme
caution. To solve the uncertainty, further prospec-
tive studies of patients with vertebrobasilar occlu-
sive disease identified immediately after stroke
by imaging techniques such as MRI with diffusion
weighted imaging are necessary.28,29 Although
small-vessel occlusive disease or lacunar stroke
has long been presumed to be associated with
a better outcome, we did not find such an associ-
ation in the multivariate model of this study of
3-month mortality (p = 0.111). Recently, it was
reported that lenticulostriate artery infarction
might be an independent predictor of functional
dependence or death.17 Stroke severity, however,
was suggested to play a more important role than
subtype classification.11 Lesions of lacunar stroke,
classified as CT lesions with an infarct-like density
that are < 1.5 cm in diameter and subcortical,
and lenticulostriate artery infarction tend to be
missed in brain CT, and often are suspected only
by clinical exclusion. Further studies of the out-
come of small-vessel occlusive disease using re-
fined eligibility criteria are needed.
In this study, the proportion of patients in
the category of small-vessel occlusion (59%) dif-
fered significantly from those of other hospital-
based studies, which, for example, varied from
29% to 43%.6,30 Because the subtype classification
in each study was conducted independently, one
possible reason for the discrepancy is interrater
agreement for the TOAST classification between in-
vestigators in these studies, which may confound
interstudy comparison. Stroke subtype variations
between studies using the TOAST classification of-
ten occurred: the proportion of patients in the “un-
determined etiology” category varied widely from
8% to 41%.31 In addition, although TOAST was
the standard classification system for clinical defi-
nition of ischemic strokes for a decade, its con-
tribution to the efficacy of stroke treatment or pre-
vention has been questioned.32
In contrast to this study of 3-month mortality
following first-ever ischemic stroke in Taiwan,
several studies have documented stroke mortality
over various durations of follow-up, and using dif-
ferent inclusion criteria. The 30-day mortality rate
was reported to be 8.1%2 or 4.4%6 for first-ever
ischemic stroke, and 8.2%3 or 5.6%5 including re-
current stroke patients. The 1-year mortality for
ischemic stroke was 18.4%.3 Recently, a study us-
ing the database of the National Health Insurance
system by Hsiao et al predicted that 30-day and 1-
year mortality of stroke following hospitalization
in medical centers in 1999 was 6.8% and 14.9%,
respectively.9 However, their study included stroke
of any type and was not restricted to first-ever
stroke. Overall, methodologic differences make
a comparison with previous studies difficult.
This study had important limitations. Some
factors, such as change in temperature, change in
blood pressure, or change in blood glucose dur-
ing the acute phase of stroke, could influence out-
come but were not collected. The case follow-up
was not complete, although we followed more
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than 90% of patients via outpatient care or phone
survey, and verified the survival status with the
Death Registry from the DOH. Furthermore, the
models used were not externally validated with
independent data because, to the best of our
knowledge, data for comparable stroke severity
measures at admission are still unavailable in
Taiwan or Asia. Another possible limitation was
the variable selection in the multivariate analysis,
which was based on clinical and statistical signifi-
cance in the univariate analysis.33 However, this
approach to variable selection also has its limit-
ations.15 Despite these limitations, our study has
considerable potential clinical value, and could be
regarded as explanatory if not pragmatic.
In conclusion, this study has demonstrated the
importance of stroke severity evaluation in stroke
patients. Although our findings should be gener-
alized with caution, this study provides useful
information about early risk stratification for pa-
tients with first-ever acute ischemic stroke. This
information is valuable for the management of
stroke patients. The association of posterior fos-
sa lesions and small lesions to 3-month mortality
after stroke illustrates the need for better imaging
modalities other than brain CT in daily practice.
Further large prospective studies are required to
validate the present results. The association of the
factors identified with 3-month mortality may pro-
vide useful information to clinicians about deci-
sion making in acute stroke care in Taiwan.
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